The Complainant is a German family-owned pharmaceutical group of companies with roots going back to 1885, when it was founded by Albert Boehringer (1861-1939) in Ingelheim am Rhein. Ever since, it has become a global research-driven pharmaceutical enterprise and it has today roughly 53,500 employees. The Complainant's two business areas are human pharmaceuticals and animal health. In 2023, the Complainant achieved net sales of 25.6 billion Euros.<\/p>\n
The Respondent is an individual residing in Hong Kong.<\/p>\n
The disputed domain name <pd-boehringer-ingelheim.com> was registered on 14 November 2025 and does not resolve to any active website. However, MX records have been set for the disputed domain name.<\/span><\/p>\n The facts asserted by the Complainant are not contested by the Respondent.<\/p>",
"other_legal_proceedings": " The Panel is not aware of any other legal proceedings which are pending or decided and which relate to the disputed domain name.<\/p>",
"no_response_filed": " The Complainant contends that the requirements of the Policy have been met and that the disputed domain name should be transferred to it.<\/p>\n No administratively compliant Response has been filed.<\/p>",
"rights": " The Complainant has, to the satisfaction of the Panel, shown the disputed domain name is identical or confusingly similar to a trademark or service mark in which the Complainant has rights (within the meaning of paragraph 4(a)(i) of the Policy).<\/p>",
"no_rights_or_legitimate_interests": " The Complainant has, to the satisfaction of the Panel, shown the Respondent to have no rights or legitimate interests in respect of the disputed domain name (within the meaning of paragraph 4(a)(ii) of the Policy).<\/p>",
"bad_faith": " The Complainant has, to the satisfaction of the Panel, shown the disputed domain name has been registered and is being used in bad faith (within the meaning of paragraph 4(a)(iii) of the Policy).<\/p>",
"procedural_factors": " The Panel is satisfied that all procedural requirements under UDRP were met and there is no other reason why it would be inappropriate to provide a decision.<\/p>",
"decision": "Accepted",
"panelists": [
"Ivett Paulovics"
],
"date_of_panel_decision": "2025-12-17 00:00:00",
"informal_english_translation": " The Complainant, conducting business under the company \/ trade name Boehringer Ingelheim Pharma GmbH & Co.KG, owns numerous trademarks including the wording “BOEHRINGER INGELHEIM” (with or without hyphen), such as:<\/p>\n International trademark (figurative) BOEHRINGER INGELHEIM, Registration No. 568844, registered since 22 March 1991 in Classes 1, 2, 3, 4, 5, 9, 10, 16, 30, 31.<\/p>\n<\/li>\n<\/ul>\n Furthermore, the Complainant owns multiple domain names consisting in the wording “BOEHRINGER INGELHEIM” (with or without hyphen), such as <boehringer-ingelheim.com> registered since 1 September 1995 and used in relation to its main website.<\/p>\n The above-mentioned rights of the Complainant are hereinafter referred to as the BOEHRINGER INGELHEIM Trademark.<\/p>\n Through its use of the BOEHRINGER INGELHEIM Trademark in connection with pharmaceutical goods and services, the Complainant has established a degree of recognition for the BOEHRINGER INGELHEIM Trademark in the relevant industry worldwide.<\/p>",
"decision_domains": {
"pd-boehringer-ingelheim.com": "TRANSFERRED"
},
"panelist": null,
"panellists_text": null
}\n